• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首例埃及骨硬化症家系中新型的硬骨素功能缺失突变。

A Novel Loss-of-Sclerostin Function Mutation in a First Egyptian Family with Sclerosteosis.

机构信息

Molecular Genetics and Enzymology Department, Human Genetics & Genome Research Division, National Research Centre, 33 El Bohouth Street (Former El Tahrir Street), P.O. Box 12622, Dokki, Giza, Egypt.

Clinical Genetics Department, Human Genetics & Genome Research Division, National Research Centre, Egypt.

出版信息

Biomed Res Int. 2015;2015:517815. doi: 10.1155/2015/517815. Epub 2015 Apr 23.

DOI:10.1155/2015/517815
PMID:25984533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4423033/
Abstract

Sclerosteosis is a rare autosomal recessive condition characterized by increased bone density. Mutations in SOST gene coding for sclerostin are linked to sclerosteosis. Two Egyptian brothers with sclerosteosis and their apparently normal consanguineous parents were included in this study. Clinical evaluation and genomic sequencing of the SOST gene were performed followed by in silico analysis of the resulting variation. A novel homozygous frameshift mutation in the SOST gene, characterized as one nucleotide cytosine insertion that led to premature stop codon and loss of functional sclerostin, was identified in the two affected brothers. Their parents were heterozygous for the same mutation. To our knowledge this is the first Egyptian study of sclerosteosis and SOST gene causing mutation.

摘要

石骨症是一种罕见的常染色体隐性遗传疾病,其特征是骨密度增加。编码硬骨素的 SOST 基因突变与石骨症有关。本研究纳入了两名患有石骨症的埃及兄弟及其明显正常的近亲父母。对 SOST 基因进行临床评估和基因组测序,然后对产生的变异进行计算机分析。在这两个受影响的兄弟中发现了 SOST 基因的一种新的纯合移码突变,特征是一个核苷酸胞嘧啶插入,导致提前终止密码子和功能性硬骨素丧失。他们的父母对此突变呈杂合状态。据我们所知,这是首例埃及石骨症和 SOST 基因突变的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d58/4423033/5d5d57f0c528/BMRI2015-517815.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d58/4423033/a2aa7eaf71e6/BMRI2015-517815.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d58/4423033/9b44ada51da4/BMRI2015-517815.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d58/4423033/8be668ac72d6/BMRI2015-517815.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d58/4423033/366d3819a791/BMRI2015-517815.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d58/4423033/680812f79bae/BMRI2015-517815.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d58/4423033/b9aea38e12cf/BMRI2015-517815.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d58/4423033/5d5d57f0c528/BMRI2015-517815.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d58/4423033/a2aa7eaf71e6/BMRI2015-517815.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d58/4423033/9b44ada51da4/BMRI2015-517815.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d58/4423033/8be668ac72d6/BMRI2015-517815.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d58/4423033/366d3819a791/BMRI2015-517815.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d58/4423033/680812f79bae/BMRI2015-517815.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d58/4423033/b9aea38e12cf/BMRI2015-517815.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d58/4423033/5d5d57f0c528/BMRI2015-517815.007.jpg

相似文献

1
A Novel Loss-of-Sclerostin Function Mutation in a First Egyptian Family with Sclerosteosis.首例埃及骨硬化症家系中新型的硬骨素功能缺失突变。
Biomed Res Int. 2015;2015:517815. doi: 10.1155/2015/517815. Epub 2015 Apr 23.
2
Novel SOST gene mutation in a sclerosteosis patient and her parents.一名骨硬化症患者及其父母的新型 SOST 基因突变。
Bone. 2013 Feb;52(2):707-10. doi: 10.1016/j.bone.2012.10.009. Epub 2012 Oct 16.
3
Sclerosteosis caused by a novel nonsense mutation of SOST in a consanguineous family.一个近亲家庭中由SOST基因新的无义突变导致的骨硬化症。
Clin Genet. 2016 Feb;89(2):205-9. doi: 10.1111/cge.12655. Epub 2015 Sep 22.
4
Novel SOST gene mutation in a sclerosteosis patient from Morocco: a case report.来自摩洛哥的一名骨硬化症患者的新型SOST基因突变:病例报告。
Eur J Med Genet. 2014 Mar;57(4):133-7. doi: 10.1016/j.ejmg.2014.02.007. Epub 2014 Mar 1.
5
Sclerosteosis: Report of type 1 or 2 in three Indian Tamil families and literature review.石骨症:三例印度泰米尔家庭 1 型或 2 型病例报告及文献复习。
Bone. 2018 Nov;116:321-332. doi: 10.1016/j.bone.2018.07.022. Epub 2018 Aug 2.
6
A Novel Mutation in a Gene Causes Sclerosteosis in a Family of Mediterranean Origin.一个基因的新突变导致一个地中海起源家族的石骨症。
Medicina (Kaunas). 2022 Jan 28;58(2):202. doi: 10.3390/medicina58020202.
7
A known SOST gene mutation causes sclerosteosis in a familial and an isolated case from Brazilian origin.已知的SOST基因突变在一个来自巴西的家族性病例和一个散发病例中导致了骨硬化症。
Genet Test. 2008 Dec;12(4):475-9. doi: 10.1089/gte.2008.0036.
8
Genetics of Sost/SOST in sclerosteosis and van Buchem disease animal models.SOST/骨硬化蛋白基因在硬骨生成症和范可尼贫血疾病动物模型中的作用。
Metabolism. 2018 Mar;80:38-47. doi: 10.1016/j.metabol.2017.10.005. Epub 2017 Oct 25.
9
First missense mutation in the SOST gene causing sclerosteosis by loss of sclerostin function.首个导致骨硬化病的 SOST 基因突变,该突变导致骨硬化素功能丧失。
Hum Mutat. 2010 Jul;31(7):E1526-43. doi: 10.1002/humu.21274.
10
A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the SOST gene.由SOST基因的一种新突变导致的两名兄弟姐妹全身性骨骼骨质增生。
Bone. 2005 Jun;36(6):943-7. doi: 10.1016/j.bone.2005.02.019.

引用本文的文献

1
Early Diagnosis and Follow-Up of a Novel Homozygous Mutation in Gene in a Child with Recurrent Facial Palsy: A Case Report and Review of the Literature.复发性面瘫患儿中一个新的纯合基因突变的早期诊断与随访:病例报告及文献复习
Int J Mol Sci. 2025 Aug 22;26(17):8175. doi: 10.3390/ijms26178175.
2
Porcupine inhibition is a promising pharmacological treatment for severe sclerosteosis pathologies.豪猪抑制是一种针对严重骨硬化症病理的有前景的药物治疗方法。
Bone Res. 2025 Apr 7;13(1):44. doi: 10.1038/s41413-025-00406-3.
3
A Novel Mutation in a Gene Causes Sclerosteosis in a Family of Mediterranean Origin.

本文引用的文献

1
Novel SOST gene mutation in a sclerosteosis patient and her parents.一名骨硬化症患者及其父母的新型 SOST 基因突变。
Bone. 2013 Feb;52(2):707-10. doi: 10.1016/j.bone.2012.10.009. Epub 2012 Oct 16.
2
Osteoblasts in osteoporosis: past, emerging, and future anabolic targets.骨质疏松症中的成骨细胞:过去、新兴和未来的合成代谢靶点。
Eur J Endocrinol. 2011 Jul;165(1):1-10. doi: 10.1530/EJE-11-0132. Epub 2011 May 4.
3
Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function.LRP4 基因中与骨过度生长相关的突变会损害骨硬化蛋白促进剂功能。
一个基因的新突变导致一个地中海起源家族的石骨症。
Medicina (Kaunas). 2022 Jan 28;58(2):202. doi: 10.3390/medicina58020202.
4
Genetics and Genomics of : Functional Analysis of Variants and Genomic Regulation in Osteoblasts.: 成骨细胞中变异的功能分析及基因组调控的遗传学和基因组学。
Int J Mol Sci. 2021 Jan 6;22(2):489. doi: 10.3390/ijms22020489.
J Biol Chem. 2011 Jun 3;286(22):19489-500. doi: 10.1074/jbc.M110.190330. Epub 2011 Apr 6.
4
First missense mutation in the SOST gene causing sclerosteosis by loss of sclerostin function.首个导致骨硬化病的 SOST 基因突变,该突变导致骨硬化素功能丧失。
Hum Mutat. 2010 Jul;31(7):E1526-43. doi: 10.1002/humu.21274.
5
Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease.范布赫姆病中一个远距离骨增强子的基因组缺失导致硬化蛋白表达失调。
Genome Res. 2005 Jul;15(7):928-35. doi: 10.1101/gr.3437105. Epub 2005 Jun 17.
6
Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation.硬化蛋白促进人成骨细胞凋亡:一种对骨形成的新调控机制。
Bone. 2004 Oct;35(4):828-35. doi: 10.1016/j.bone.2004.05.023.
7
Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist.硬化素是一种由骨细胞表达的骨形成负调节因子,但不是经典的骨形态发生蛋白拮抗剂。
J Exp Med. 2004 Mar 15;199(6):805-14. doi: 10.1084/jem.20031454.
8
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.骨细胞通过骨硬化蛋白(一种新型骨形态发生蛋白拮抗剂)对骨形成的调控。
EMBO J. 2003 Dec 1;22(23):6267-76. doi: 10.1093/emboj/cdg599.
9
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease.范布希姆病患者中SOST基因下游52 kb缺失的鉴定。
J Med Genet. 2002 Feb;39(2):91-7. doi: 10.1136/jmg.39.2.91.
10
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.骨发育异常骨硬化症是由SOST基因产物(一种含新型胱氨酸结的蛋白质)缺失所致。
Am J Hum Genet. 2001 Mar;68(3):577-89. doi: 10.1086/318811. Epub 2001 Feb 9.